LON:TRX Tissue Regenix Group (TRX) Share Price, News & Analysis → The 2024 crypto bull run has already started — don’t get left behind (From InvestorPlace) (Ad) Free TRX Stock Alerts GBX 61 -0.05 (-0.08%) (As of 05:32 AM ET) Add Compare Share Share Today's Range 61▼ 61.4050-Day Range 59.80▼ 7152-Week Range 48▼ 72.94Volume27,579 shsAverage Volume61,428 shsMarket Capitalization£43.05 millionP/E RatioN/ADividend Yield4.12%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsInsider TradesStock AnalysisChartCompetitorsInsider Trades Get Tissue Regenix Group alerts: Email Address Ad Stansberry ResearchControversial CEO explains new way to amass wealthThere's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject About Tissue Regenix Group Stock (LON:TRX)Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth. In addition, the company offers DermaPure, a decellularised dermal allograft for reinforcement, repair, and replacement of damaged or inadequate integumental tissue and other homologous uses of human integument; and SurgiPure XD, a decellularised porcine dermal reconstructive tissue matrix for the repair of hernias and body wall defects. Further, it provides OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedic; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company offers DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; Matrix OI 100 DBM for non-structural bone-grafting; Matrix OI Strips and Blocks, a stem cell containment human scaffold; AmnioWorks to optimise membrane defects; and sports medicine products. Tissue Regenix Group plc was incorporated in 2006 and is based in Garforth, the United Kingdom.Read More TRX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRX Stock News HeadlinesMay 3, 2024 | americanbankingnews.comTissue Regenix Group (LON:TRX) Stock Price Passes Above 200-Day Moving Average of $58.73April 6, 2024 | finance.yahoo.comTissue Regenix Group plc (LON:TRX): Are Analysts Optimistic?May 7, 2024 | InvestorPlace (Ad)You need to know these two things about AI stocks ASAP…For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.March 21, 2024 | finance.yahoo.comTissue Regenix unveils growth strategy and positive EBITDA milestoneJanuary 25, 2024 | lse.co.ukTissue Regenix Group Share ChatJanuary 25, 2024 | finance.yahoo.comInvestors in Tissue Regenix Group (LON:TRX) from five years ago are still down 90%, even after 16% gain this past weekNovember 23, 2023 | morningstar.comTissue Regenix Group PLC TRXSeptember 8, 2023 | finance.yahoo.comTissue Regenix Group First Half 2023 Earnings: US$0.013 loss per share (vs US$0.023 loss in 1H 2022)May 7, 2024 | InvestorPlace (Ad)You need to know these two things about AI stocks ASAP…For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.September 5, 2023 | finance.yahoo.comTissue Regenix Group says "disciplined approach" paying off at half-year stageApril 18, 2023 | finance.yahoo.comImproved Revenues Required Before Tissue Regenix Group plc (LON:TRX) Shares Find Their FeetMarch 15, 2023 | bbc.co.ukTissue by Imtiaz DharkerFebruary 2, 2023 | finance.yahoo.comTissue Regenix Group "has the opportunity to become a global commercial organisation"January 31, 2023 | proactiveinvestors.comTissue Regenix highlights 20%-plus revenue growth across all three of its key business segments in 2022January 18, 2023 | proactiveinvestors.comTissue Regenix strikes China distribution deal with Hong Kong-based groupJanuary 18, 2023 | proactiveinvestors.comTissue Regenix shares rise 7% after China deal; broker says Kingsung Medical tie-up is 'encouraging'January 10, 2023 | finance.yahoo.comWhen Will Tissue Regenix Group plc (LON:TRX) Breakeven?December 7, 2022 | proactiveinvestors.comTissue Regenix extends VNEW allograft range to support SUI treatmentsNovember 22, 2022 | proactiveinvestors.comTissue Regenix inks German distribution dealSeptember 27, 2022 | proactiveinvestors.comTissue Regenix on course for underlying profitability in Q4, says research houseSeptember 7, 2022 | proactiveinvestors.comTissue Regenix says recent growth 'is sustainable' after commercial reorganisationSeptember 7, 2022 | proactiveinvestors.comTissue Regenix says first-half losses narrow on sales growth, cost managementSeptember 7, 2022 | proactiveinvestors.comTissue Regenix says first-half losses narrow on sales growth, cost managementAugust 11, 2022 | uk.finance.yahoo.comHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correctAugust 3, 2022 | finance.yahoo.comWhen Will Tissue Regenix Group plc (LON:TRX) Become Profitable?July 25, 2022 | msn.comSMALL CAP IDEA: Tissue Regenix shows regeneration is the way to healthy growthJuly 21, 2022 | proactiveinvestors.comTissue Regenix: Four-pronged strategy delivers double-digit growthSee More Headlines Receive TRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/02/2020Today5/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:TRX CUSIPN/A CIKN/A Webwww.tissueregenix.com Phone+44-1904-567609FaxN/AEmployees82Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E Ratio112.91 P/E GrowthN/ANet Income£-1,710,000.00 Net Margins-5.81% Pretax MarginN/A Return on Equity-5.55% Return on Assets-0.55% Debt Debt-to-Equity Ratio32.01 Current Ratio4.03 Quick Ratio2.36 Sales & Book Value Annual Sales£29.49 million Price / Sales1.47 Cash FlowGBX 10.75 per share Price / Cash Flow5.70 Book ValueGBX 43 per share Price / Book1.43Miscellaneous Outstanding Shares70,570,000Free FloatN/AMarket Cap£43.26 million OptionableNot Optionable Beta1.48 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Daniel Ray Lee (Age 63)CEO & Director Comp: $498.95kMr. David Claiborne Cocke (Age 59)CFO & Executive Director Comp: $294.87kMs. Christine RowleyTechnical & Operations Director - UKTina TrimbleSenior Vice President, Donor Services - U.S.Ms. Kirsten Mary LundEMEA Business Director & Company SecretaryKey CompetitorsArecor TherapeuticsLON:ARECBiodexa PharmaceuticalsLON:MTPHCollagen Solutions plc (COS.L)LON:COSC4X DiscoveryLON:C4XD4D pharmaLON:DDDDView All CompetitorsInsidersBrian PhillipsBought 6,773 shares on 9/15/2023Total: £365,742.00 ($54.00/share)View All Insider Transactions TRX Stock Analysis - Frequently Asked Questions How have TRX shares performed in 2024? Tissue Regenix Group's stock was trading at GBX 52 on January 1st, 2024. Since then, TRX shares have increased by 17.3% and is now trading at GBX 61. View the best growth stocks for 2024 here. How were Tissue Regenix Group's earnings last quarter? Tissue Regenix Group plc (LON:TRX) announced its quarterly earnings data on Wednesday, September, 2nd. The company reported ($0.16) earnings per share (EPS) for the quarter. Tissue Regenix Group had a negative net margin of 5.81% and a negative trailing twelve-month return on equity of 5.55%. What other stocks do shareholders of Tissue Regenix Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tissue Regenix Group investors own include Argos Therapeutics (ARGSQ), Swedbank AB (publ) (SWDBY), Trevena (TRVN), Allied Minds (ALM), ArQule (ARQL), Boeing (BA), CIRCOR International (CIR), WisdomTree Middle East Dividend Fund (GULF) and W.W. Grainger (GWW). How do I buy shares of Tissue Regenix Group? Shares of TRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:TRX) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.